Zobrazeno 1 - 10
of 25
pro vyhledávání: '"J F, Bourke"'
Publikováno v:
Irish medical journal. 113(3)
Aim To compare the relative efficiencies of skin excisions in primary and secondary care. Methods We compared the benign: malignant ratio for specimens referred by General Practice, General Surgery and the Skin Cancer Service to the regional patholog
Publikováno v:
Irish medical journal. 112(7)
Aim Our aim was to review cases of melanoma diagnosed histologically in UHK in 2016 and to compare them to cases of melanoma nationally and in Kerry. Methods For each patient we recorded age, Breslow depth, and shortest distance to travel by car and
Publikováno v:
Clinical and Experimental Dermatology. 35:e62-e64
Publikováno v:
British Journal of Dermatology. 140:102-105
There is conflicting evidence regarding the reproducibility of patch testing. Discordant results have been reported in up to 44% of cases. The clinical relevance of these discordant patch tests has not been previously assessed. We studied 383 consecu
Publikováno v:
British Journal of Dermatology. 134:705-709
Publikováno v:
Clinical and experimental dermatology. 37(2)
Summary Very little is known about the aetiology of eccrine porocarcinoma (EP), a rare malignant sweat-gland tumour. Most reported cases have arisen de novo, or from a benign eccrine poroma. We report an unusual case, in which eccrine porocarcinoma a
Publikováno v:
Clinical and experimental dermatology. 35(3)
Recombinant interferon (IFN)β is currently the most commonly prescribed treatment for long-term immunomodulation in multiple sclerosis, and is generally a well-tolerated treatment. Reactions to IFNβ at the injection site are a common side effect, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22338c04956275a3aaee5b2f9375c0f4
https://europepmc.org/articles/PMC2077407/
https://europepmc.org/articles/PMC2077407/
Publikováno v:
The British journal of dermatology. 154(5)
Possible exacerbating factors are a major concern of parents of children with atopic eczema (AE). However, there is minimal evidence for their direct role in leading to disease flares.To assess the association between 'trigger factors' and disease fl
Allergy to phosphorus sesquisulfide: 0.5% pet. is a more appropriate concentration for patch testing
Publikováno v:
Contact Dermatitis. 37:210-212
Patch testing was performed with phosphorus sesquisulfide P4S3 in 2 groups containing equal numbers of patients using different concentrations (0.5% P4S3 in pet. and 1% P4S3 in pet., the usual suggested test concentration as recommended by the Intern